A Synthesis of drug reimbursement decision-making processes in organisation for economic co-operation and development countries

Value in Health

Volumn 17, Issue 1, 2014, Pages 98-108

  Barnieh, Lianne ^a   Manns, Braden ^a   Harris, Anthony ^b   Blom, Marja ^c   Donaldson, Cam ^d   Klarenbach, Scott ^e   Husereau, Don ^f   Lorenzetti, Diane ^g   Clement, Fiona ^g  

^a UNIVERSITY OF CALGARY   (Canada)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF HELSINKI   (Finland)

^d GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

decision making; formulary management; international health care; prescription drug coverage

Indexed keywords

ELEMENT; PRESCRIPTION DRUG;

ACCURACY; ARTICLE; DECISION MAKING; DRUG SYNTHESIS; ECONOMICS; HUMAN; INSURANCE; OUTPATIENT; PRIORITY JOURNAL; REIMBURSEMENT;

DECISION MAKING; FORMULARY MANAGEMENT; INTERNATIONAL HEALTH CARE; PRESCRIPTION DRUG COVERAGE;

DECISION MAKING; FORMULARIES AS TOPIC; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; INSURANCE, PHARMACEUTICAL SERVICES; PRESCRIPTION DRUGS; WORLD HEALTH;

EID: 84892588153     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2013.10.008     Document Type: Article

References (35)

1. Organisation for Economic Co-operation and Development OECD Health Policy Studies: Pharmaceutical Pricing Policies in a Global Market 2008 Organisation for Economic Co-operation and Development Paris
2. Canadian Institute for Health Information Drug Expenditure in Canada, 1985 to 2006 2007 Canadian Institute for Health Information Ottawa
3. M. McMahon, S. Morgan, and C. Mitton The common drug review: a NICE start for Canada? Health Policy 77 2006 339 351
4. F. Clement, A. Harris, and J. Li et al. Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia and Canada JAMA 302 2009 1437 1443
5. Stafinski T, Menon D. A Comparison of International Models for Common Drug Review Processes in Publicly Funded Health Care Systems. Edmonton, Alberta, Canada: Institute for Health Economics, 2003. Working Paper 03-09
6. T. Iizuka The Economics of Pharmaceutical Pricing and Physician Prescribing in Japan 2008 Aoyama Gakuin University Tokyo, Japan
7. C. McCabe, K. Claxton, and A. Culyer The NICE cost-effectiveness threshold: what it is and what that means Pharmacoeconomics 26 2008 733 744
8. J. Raftery Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand Med J Aus 188 2008 26 28
9. J. Lexchin, and B. Mintzes Medicine reimbursement recommendations in Canada, Australia and Scotland Am J Manag Care 14 2008 581 588
10. A. Laupacis On bias and transparency in the development of influential recommendations CMAJ 174 2006 335 336
11. F. Gartland New cost rules may prevent patients accessing drugs Irish Times 2012 Available from: http://www.irishtimes.com/premium/loginpage? destination=http://www.irishtimes.com/news/new-cost-rules-may-prevent-patients- accessing-drugs-1.516419. [Accessed December 23, 2013]
12. B.-M. Yang, E. Bae, and J. Kim Economic evaluation and pharmaceutical reimbursement reform in South Korea's National Health Insurance Health Aff 27 2008 179 187
13. S. Vogler, J. Espin, and C. Habl Pharmaceutical pricing and reimbursement information (PPRI) - new PPRI analysis including Spain Pharm Policy Law 11 2009 213 234
14. R. Janiszewski, and K. Bondaryk Pharmaceutical Pricing and Reimbursement Information 2007 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Austria. Vienna, Austria
15. A. DeSwaef, and Y. Antonissen Pharmaceutical Pricing and Reimbursement Information 2008 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Belgium. Vienna, Austria
16. E. Thomsen, S. Er, and P. Rasmussen Pharmaceutical Pricing and Reimbursement Information 2008 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Denmark. Vienna, Austria
17. K. Pudersell, A. Vetka, and L. Rootslane et al. Pharmaceutical Pricing and Reimbursement Information 2007 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Estonia. Vienna, Austria
18. S. Peura, S. Rajaniemi, and U. Kurkijarvi Pharmaceutical Pricing and Reimbursement Information 2007 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Finland. Vienna, Austria
19. E. Van Ganse, G. Chamba, and G. Bruet et al. Pharmaceutical Pricing and Reimbursement Information 2008 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG France. Vienna, Austria
20. T. Stargardt, and R. Busse Pharmaceutical Pricing and Reimbursement Information 2008 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Germany. Vienna, Austria
21. T. Kovacs, P. Rozsa, and S. Szigeti et al. Pharmaceutical Pricing and Reimbursement Information 2007 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Hungary. Vienna, Austria
22. D. Elliott, and G. Byrne Pharmaceutical Pricing and Reimbursement Information 2007 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Ireland. Vienna, Austria
23. N. Martini, P. Folino-Gallo, and S. Montilla Pharmaceutical Pricing and Reimbursement Information 2007 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Italy. Vienna, Austria
24. H. Festoy, K. Sveen, and L.-M. Yu et al. Pharmaceutical Pricing and Reimbursement Information 2008 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Norway. Vienna, Austria
25. I. Teixeira, and I. Vieira Pharmaceutical Pricing and Reimbursement Information 2008 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Portugal. Vienna, Austria
26. T. Redman, and M. Hoggard Pharmaceutical Pricing and Reimbursement Information 2007 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG Sweden. Vienna, Austria
27. D. Palnoch, D. Kullman, and J. Sherriff et al. Pharmaceutical Pricing and Reimbursement Information 2007 Gesundheit Osterreich GmbH/Geschaftsbereich OBIG United Kingdom. Vienna, Austria
28. V. Paris, and E. Docteur Pharmaceutical Pricing and Reimbursement Policies in Canada 2006 Organisation for Economic Co-operation and Development Paris
29. P. Moise, and E. Docteur Pharmaceutical Pricing and Reimbursement Policies in Sweden 2007 Organisation for Economic Co-operation and Development Paris
30. V. Paris, and E. Docteur Pharmaceutical Pricing and Reimbursement Policies in Switzerland 2007 Organisation for Economic Co-operation and Development Paris
31. P. Folino-Gallo, S. Montilla, M. Bruzzone, and N. Martini Pricing and reimbursement of pharmaceuticals in Italy Eur J Health Econ 9 2008 305 310
32. T. Jirawattanapisal, P. Kingkaew, T. Lee, and M. Yang Evidence-based decision-making in Asia-Pacific with rapidly changing health-care systems: Thailand, South Korea, and Taiwan Value Health 12 Suppl 2009 S4 11
33. G. Liu, T. Fukuda, and C. Lee et al. Evidence-based decision-making on medical technologies in China, Japan, and Singapore Value Health 12 Suppl 2009 S12 S17
34. J. Davidova, L. Praznovcova, and C. Lundborg Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden Pharm World Sci 30 2008 57 64
35. S. Kleijnen, W. Goettsh, and A. d'Andon et al. EUnetNTA JA WP5: Relative Effecitveness Assessment (REA) of Pharmaceuticals 2011 EUnetHTA Copenhagen, Denmark